Home › Neurofibromatosis
Neurofibromatosis clinical trials recruiting in the U.S.
7 studies for Neurofibromatosis are recruiting participants at sites across the United States.
Neurofibromatosis (NF) is a genetic disorder that causes tumors to grow on nerves. Learn about the types, their symptoms, and how they are treated.
Recently updated studies
Natural History Study of Patients With Neurofibromatosis Type 2
RecruitingObservational study
Ages 8 to 75 · All sexes · Updated Sep 1, 2026 · NCT00598351Glioma Developmental and HyperActive Ras Tumor (DHART) Board
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05489783Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
Recruiting
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT07233408Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT07102394PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06961565Mirdametinib in Patients With Advanced NF1-mutant Melanoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 19, 2025 · NCT07237100Neurofibromatosis (NF) Registry Portal
RecruitingObservational study
All ages · All sexes · Updated Aug 30, 2023 · NCT01885767From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.